Characterization of fluoroquinolone resistance in Escherichia coli strains from ruminants

Journal of Veterinary Diagnostic Investigation

Volumn 20, Issue 3, 2008, Pages 342-345

  Jurado, Sonia ^a   Orden, José A ^a   Horcajo, Pilar ^a   De La Fuente, Ricardo ^a   Ruiz Santa Quiteria, José A ^a   Martínez Pulgarín, Susana ^a   Domínguez Bernal, Gustavo ^a  

^a UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

Author keywords

Escherichia coli; Fluoroquinolone resistance; gyrA; parC; qnrA; Ruminants

Indexed keywords

ANIMALIA; BOVIDAE; ESCHERICHIA COLI;

ANTIINFECTIVE AGENT; CIPROFLOXACIN; DNA TOPOISOMERASE (ATP HYDROLYSING); DNA TOPOISOMERASE IV; ENROFLOXACIN; QUINOLONE DERIVATIVE;

AMINO ACID SUBSTITUTION; ANIMAL; ANIMAL DISEASE; ARTICLE; CATTLE; CATTLE DISEASE; DRUG EFFECT; ENTEROBACTER INFECTION; ESCHERICHIA COLI; GENETICS; MICROBIOLOGY; MULTIDRUG RESISTANCE; SHEEP; SHEEP DISEASE;

AMINO ACID SUBSTITUTION; ANIMALS; ANTI-BACTERIAL AGENTS; CATTLE; CATTLE DISEASES; CIPROFLOXACIN; DNA GYRASE; DNA TOPOISOMERASE IV; DRUG RESISTANCE, MULTIPLE, BACTERIAL; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; FLUOROQUINOLONES; SHEEP; SHEEP DISEASES;

EID: 54549123554     PISSN: 10406387     EISSN: None     Source Type: Journal    
DOI: 10.1177/104063870802000314     Document Type: Article

References (22)

1. Beutin L, Zimmermann S, Gleier K: 1998, Human infections with Shiga toxin-producing Escherichia coli other than serogroup O157 in Germany. Emerg Infect Dis 4: 635-639.
2. Caprioli A, Morabito S, Brugère H, Oswald E: 2005, Enterohaemorrhagic Escherichia coli: emerging issues on virulence and modes of transmission. Vet Res 36:289-311.
3. Everett MJ, Fang Jin Y, Ricci V, Piddock LJV: 1996, Contributions of individual mechanisms to fluoroquinolone resistance in 36 Escherichia coli strains isolated from humans and animals. Antimicrob Agents Chemother 40:2380-2386.
4. Giraud E, Leroy-Sétrin S, Flaujac G, et al.: 2001, Characterization of high-level fluoroquinolone resistance in Escherichia coli O78:K80 isolated from turkeys. J Antimicrob Chemother 47:341-343.
5. Heising P: 1996, Genetic evidence for a role of parC mutations in development of high-level fluoroquinolone resistance in Escherichia coli. Antimicrob Agents Chemother 40:879-885.
6. Hopkins KL, Davies RH, Threlfall EJ: 2005, Mechanisms of quinolone resistance in Escherichia coli and Salmonella: recent developments. Int J Antimicrob Agents 25:358-373.
7. Le Bouguénec C, Bertin Y: 1999, AFA and F17 adhesins produced by pathogenic Escherichia coli strains in domestic animals. Vet Res 30:317-342.
8. National Committee for Clinical Laboratory Standards (NCCLS): 2002, Performance standards for antimicrobial disk and dilution susceptibility tests for bacteria isolated from animals, 2nd ed., approved standard M31-A2., NCCLS, Wayne, PA.
9. National Committee for Clinical Laboratory Standards (NCCLS): 2004, Performance standards for antimicrobial susceptibility testing, 14th international supplement M100-S14., NCCLS, Wayne, PA.
10. Nordmann P, Poirel L: 2005, Emergence of plasmid-mediated resistance to quinolones in Enterobacteriaceae. J Antimicrob Chemother 56:463-469.
11. Orden JA, Ruiz-Santa-Quiteria JA, Cid D, et al.: 2001, Quinolone resistance in potentially pathogenic and nonpathogenic Escherichia coli strains isolated from healthy ruminants. J Antimicrob Chemother 48:421-424.
12. Orden JA, Ruiz-Santa-Quiteria JA, García S, et al.: 1999, In vitro activities of cephalosporins and quinolones against Escherichia coli strains isolated from diarrheic dairy calves. Antimicrob Agents Chemother 43:510-513.
13. Orden JA, Ruiz-Santa-Quiteria JA, García S, et al.: 2000, Quinolone resistance in Escherichia coli strains isolated from diarrhoeic lambs in Spain. Vet Rec 147:576-578.
14. Robicsek A, Strahilevitz J, Sahm DF, et al.: 2006, qnr Prevalence in ceftazidime-resistant Enterobacteriaceae isolates from the United States. Antimicrob Agents Chemother 50:2872-2874.
15. Rodríguez-Martínez JM, Pascual A, García I, Martínez-Martínez L: 2003, Detection of the plasmid-mediated quinolone resistance determinant qnr among clinical isolates of Klebsiella pneumoniae producing AmpC-type β-lactamase. J Antimicrob Chemother 52:703-706.
16. Sáenz Y, Zarazaga M, Briñas L, et al.: 2003, Mutations in gyrA and parC genes in nalidixic acid-resistant Escherichia coli strains from food products, humans and animals. J Antimicrob Chemother 51:1001-1005.
17. Saito R, Kumita W, Sato K, et al.: 2007, Detection of plasmid-mediated quinolone resistance associated with qnrA in an Escherichia coli clinical isolate producing CTX-M-9 β-lactamase in Japan. Int J Antimicrob Agents 29:600-602.
18. Vila J, Ruiz J, Goñi P, Jiménez de Anta T: 1996, Detection of mutations in parC in quinolone-resistant clinical isolates of Escherichia coli. Antimicrob Agents Chemother 40:491-493.
19. Wang M, Tran JH, Jacoby GA, et al.: 2003, Plasmid-mediated quinolone resistance in clinical isolates of Escherichia coli from Shanghai, China. Antimicrob Agents Chemother 47:2242-2248.
20. Webber M, Piddock LJV: 2001, Quinolone resistance in Escherichia coli. Vet Res 32:275-284.
21. White DG, Piddock LJV, Maurer JJ, et al.: 2000, Characterization of fluoroquinolone resistance among veterinary isolates of avian Escherichia coli. Antimicrob Agents Chemother 44:2897-2899.
22. Yang H, Chen S, White DG, et al.: 2004, Characterization of multiple-antimicrobial-resistant Escherichia coli isolates from diseased chickens and swine in China. J Clin Microbiol 42:3483-3489.